Camilla Nero

1.8k total citations
89 papers, 1.2k citations indexed

About

Camilla Nero is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Camilla Nero has authored 89 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Reproductive Medicine, 40 papers in Obstetrics and Gynecology and 30 papers in Oncology. Recurrent topics in Camilla Nero's work include Ovarian cancer diagnosis and treatment (59 papers), Endometrial and Cervical Cancer Treatments (37 papers) and PARP inhibition in cancer therapy (16 papers). Camilla Nero is often cited by papers focused on Ovarian cancer diagnosis and treatment (59 papers), Endometrial and Cervical Cancer Treatments (37 papers) and PARP inhibition in cancer therapy (16 papers). Camilla Nero collaborates with scholars based in Italy, Japan and United States. Camilla Nero's co-authors include Giovanni Scambia, Anna Fagotti, Francesca Ciccarone, Domenica Lorusso, Francesco Fanfani, Antonella Pietragalla, Giuseppe Vizzielli, Gabriella Ferrandina, Valerio Gallotta and Gennaro Daniele and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Camilla Nero

77 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Camilla Nero Italy	22	660	475	335	289	204	89	1.2k
Antonio Santillan United States	21	880 1.3×	469 1.0×	676 2.0×	290 1.0×	440 2.2×	27	1.6k
I. Vergote Belgium	18	1.1k 1.6×	755 1.6×	662 2.0×	392 1.4×	201 1.0×	77	1.7k
Pierre‐Alexandre Just France	17	308 0.5×	265 0.6×	163 0.5×	269 0.9×	415 2.0×	45	1.1k
Martin Heubner Germany	18	312 0.5×	247 0.5×	117 0.3×	283 1.0×	198 1.0×	47	869
Moon‐Hong Kim South Korea	17	274 0.4×	505 1.1×	210 0.6×	167 0.6×	117 0.6×	30	841
M.L. Carcangiu Italy	15	334 0.5×	326 0.7×	143 0.4×	390 1.3×	248 1.2×	31	1.1k
Kyung Jin Eoh South Korea	19	286 0.4×	246 0.5×	199 0.6×	240 0.8×	335 1.6×	60	934
Jørn Andersen Denmark	20	425 0.6×	209 0.4×	267 0.8×	461 1.6×	165 0.8×	36	1.0k
Alexandre André Balieiro Anastácio da Costa Brazil	18	276 0.4×	246 0.5×	174 0.5×	301 1.0×	343 1.7×	64	832
Asima Mukhopadhyay India	17	377 0.6×	252 0.5×	123 0.4×	641 2.2×	520 2.5×	59	1.3k

Countries citing papers authored by Camilla Nero

Since Specialization

Citations

This map shows the geographic impact of Camilla Nero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Nero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Nero more than expected).

Fields of papers citing papers by Camilla Nero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilla Nero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Nero. The network helps show where Camilla Nero may publish in the future.

Co-authorship network of co-authors of Camilla Nero

This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Nero. A scholar is included among the top collaborators of Camilla Nero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Nero. Camilla Nero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bizzarri, Nicolò, Víctor Lago, Núria Agustí, et al.. (2025). Incidence And Impact Of Low Volume Lymph Node Metastasis In Apparent Early-Stage Ovarian Cancer – MICR-OVARY Study.. International Journal of Gynecological Cancer. 35(2). 100347–100347.

Pavone, Matteo, Maria Chiara Sighinolfi, Camilla Nero, et al.. (2025). Image-guided real-time optical biopsy in oncologic surgery: a systematic review of the role of confocal microscopy in the era of digital surgery. European Journal of Surgical Oncology. 51(11). 110412–110412.

Nero, Camilla, Simona Duranti, Floriana Camarda, et al.. (2025). POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a large prospective single‐center cohort. Cancer. 131(3). e35731–e35731. 2 indexed citations

Capasso, Ilaria, Emanuele Perrone, Simona Duranti, et al.. (2025). Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience. European Journal of Cancer. 220. 115344–115344. 2 indexed citations

Tortorella, Lucia, Serena Cappuccio, Diana Giannarelli, et al.. (2024). Distribution and prognostic role of BRCA status in elderly ovarian cancer patients. Gynecologic Oncology. 182. 57–62. 1 indexed citations

Marino, Ignazio R., Simona Duranti, Luciano Giacò, et al.. (2024). 60P Exploration of homologous recombination deficiency testing in ovarian cancer: Insight from an Italian referral center. ESMO Open. 9. 103567–103567.

Bizzarri, Nicolò, et al.. (2024). Future of sentinel node biopsy in ovarian cancer. Current Opinion in Oncology. 36(5). 412–417. 1 indexed citations

Lago, Víctor, Nicolò Bizzarri, Núria Agustí, et al.. (2024). Key issues in diagnostic accuracy of sentinel lymph node biopsy in early-stage ovarian cancer: systematic review and meta-analysis. International Journal of Gynecological Cancer. 34(11). 1787–1794. 5 indexed citations

Franceschini, Gianluca, Camilla Nero, Ida Paris, et al.. (2024). Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital. Journal of Personalized Medicine. 14(4). 371–371.

10.

Nero, Camilla, Maria De Bonis, Cláudia Marchetti, et al.. (2023). #759 Comprehensive cancer genomic profiling in matched primary tumor and brain metastasis samples of ovarian cancer patients: a single-institution case series. A25–A26. 1 indexed citations

11.

Schwameis, Richard, Francesco Fanfani, Christoph Ebner, et al.. (2023). Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centres. European Journal of Cancer. 193. 113317–113317. 39 indexed citations

12.

Musacchio, Lucia, Vanda Salutari, Sandro Pignata, et al.. (2022). 2022-RA-1540-ESGO MITO 25.1: a randomized, molecular driven phase II trial of carboplatin-paclitaxel-bevacizumab vs carboplatin-paclitaxel-bevacizumab-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced (Stage III B-C-IV) ovarian, primary peritoneal and fallopian tube cancer. International Journal of Gynecological Cancer. 32. A347–A348.

13.

Bizzarri, Nicolò, Emanuele Perrone, Lucia Tortorella, et al.. (2022). 2022-RA-1335-ESGO The impact of combination of systemic inflammatory and molecular markers on survival of apparent early-stage endometrial cancer. International Journal of Gynecological Cancer. 32. A145–A145. 1 indexed citations

14.

Arciuolo, Damiano, Antonio Travaglino, Angela Santoro, et al.. (2022). L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma. Cancers. 14(15). 3635–3635. 2 indexed citations

15.

Bartoletti, Michele, Alice Bergamini, Gaia Giannone, et al.. (2022). A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group. International Journal of Gynecological Cancer. 32(9). 1205–1207. 4 indexed citations

16.

Bizzarri, Nicolò, Camilla Nero, Francesca Ciccarone, et al.. (2021). Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital. Journal of Personalized Medicine. 12(1). 3–3. 4 indexed citations

17.

Pietragalla, Antonella, Simona Duranti, Gennaro Daniele, et al.. (2021). Oregovomab: an investigational agent for the treatment of advanced ovarian cancer. Expert Opinion on Investigational Drugs. 30(2). 103–110. 8 indexed citations

18.

Duranti, Simona, Antonella Pietragalla, Gennaro Daniele, et al.. (2021). Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data. Cancers. 13(9). 2089–2089. 29 indexed citations

19.

Turco, Luigi Carlo, Virginia Vargiu, Camilla Nero, et al.. (2020). Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye. International Journal of Gynecological Cancer. 30(5). 712–713. 5 indexed citations

20.

Uccella, Stefano, Camilla Nero, Enrico Vizza, et al.. (2019). Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY). American Journal of Obstetrics and Gynecology. 221(4). 324.e1–324.e10. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact